SWOG clinical trial number
SWOG-7519
A Comparison of Methotrexate with a Three-Drug Combination, Methotrexate, Methyl-CCNU & Bleomycin for Patients with Advanced Squamous Cell Carcinoma of the Head and Neck Region
Closed
Phase
Abbreviated Title
A Comparison of Methotrexate with a Three-Drug Combination, Methotrexate, Methyl-CCNU & Bleomycin for Patients with Advanced Squamous Cell Carcinoma of the Head and Neck Region
Activated
10/17/1975
Closed
03/01/1978
Publication Information Expand/Collapse
1980
A comparison of methotrexate (M) with methyl-CCNU (MC) and Bleomycin (B) in patients with advanced squamous cell carcinoma of the head and neck (H & N) region: A Southwest Oncology Group study.